骨髓生成
免疫
免疫学
病毒学
骨髓
医学
利什曼原虫
减毒疫苗
墨西哥利什曼原虫
生物
免疫
利什曼病
利什曼原虫
免疫系统
接种疫苗
抗体
细胞免疫
作者
Nazli Azodi,Thalia Pacheco‐Fernández,Laura Klenow,Hannah Markle,Nikki Tirrell,Alexander Murray,Meghan L. M. Brino,Supriya Kumar,Nirmallya Acharyya,Erica Silberstein,Abhay R. Satoskar,Spyros Karaiskos,Hira Lal Nakhasi,Sreenivas Gannavaram
出处
期刊:iScience
[Cell Press]
日期:2026-10-15
卷期号:29 (11): 117816-117816
标识
DOI:10.1016/j.isci.2026.117816
摘要
Leishmaniasis lacks an effective vaccine. We developed a live-attenuated Leishmania major Centrin-deficient strain ( LmCen −/− ) that is safe and protective in murine and canine models through IFN-γ-producing effector T cells. Because persistent low-level infection supports durable immunity, we investigated latent parasites and immune remodeling in the bone marrow. Dual single-cell RNA sequencing detected parasitized bone marrow cells 28 days after intradermal inoculation with either virulent LmWT or attenuated LmCen −/− . Flow cytometry showed increased myelopoiesis following LmCen −/− immunization compared with LmWT infection. Cell-cell communication analysis implicated enhanced granulin-Sort3 signaling as a potential driver of this response. Bone marrow monocytes from LmCen −/− -immunized mice efficiently cleared virulent LmWT parasites in co-culture, consistent with the induction of trained innate immunity. These findings identify the bone marrow as an active site of anti- Leishmania immune programming and suggest that LmCen −/− vaccination promotes durable protection through coordinated adaptive and innate mechanisms.
科研通智能强力驱动
Strongly Powered by AbleSci AI